Moreover, WRAP53 recently was found to be a telomerase holoenzyme subunit and present an essential role for telomere elongation, in addition, WRAP53 overexpression have been described in different human cancer cells, associated with a poorer prognosis suggesting that it might be an oncogene and as potential target for cancer therapy [64,65,66,67]. Here, WRAP53 is linked to cancer.